Guess Jennifer C, McCance Dennis J
Department of Microbiology and Immunology, University of Rochester, New York 14642, USA.
J Virol. 2005 Dec;79(23):14852-62. doi: 10.1128/JVI.79.23.14852-14862.2005.
Infection with high-risk human papillomavirus (HPV) types, particularly types 16 and 18, contributes to 90% of cervical cancer cases. HPV infects cutaneous or mucosal epithelium, tissue that is monitored for microbial infection or damage by Langerhans cells. In lesions produced by HPV type 16, there is a reduction in numbers of immune cells, especially Langerhans cells. Langerhans precursor cells selectively express CCR6, the receptor for macrophage inflammatory protein 3alpha (MIP-3alpha), and function as potent immune responders to inflamed epithelium and initiators of the innate immune response. It has been reported that E6 and E7 of high-risk HPVs interfere with immune mediators in order to suppress the recruitment of immune cells and antiviral activities of infected cells. Here we show that, following proinflammatory stimulus, HPV-16 E6 and E7 inhibit MIP-3alpha transcription, resulting in suppression of the migration of immature Langerhans precursor-like cells. Interestingly, the E6 and E7 proteins from the low-risk HPV types also inhibited MIP-3alpha transcription. These results suggest that one mechanism by which HPV-infected cells suppress the immune response may be through the inhibition of a vital alert signal, thus contributing to the persistence of HPV infection.
高危型人乳头瘤病毒(HPV)感染,尤其是16型和18型,导致了90%的宫颈癌病例。HPV感染皮肤或黏膜上皮,而朗格汉斯细胞会监测这些组织是否受到微生物感染或损伤。在16型HPV产生的病变中,免疫细胞数量减少,尤其是朗格汉斯细胞。朗格汉斯前体细胞选择性表达CCR6,即巨噬细胞炎性蛋白3α(MIP-3α)的受体,并作为对炎症上皮的有效免疫应答者和先天免疫反应的启动者发挥作用。据报道,高危型HPV的E6和E7会干扰免疫介质,以抑制免疫细胞的募集和受感染细胞的抗病毒活性。在此我们表明,在促炎刺激后,HPV-16 E6和E7抑制MIP-3α转录,导致未成熟的朗格汉斯前体样细胞迁移受到抑制。有趣的是,低危型HPV的E6和E7蛋白也抑制MIP-3α转录。这些结果表明,HPV感染细胞抑制免疫反应的一种机制可能是通过抑制重要的警报信号,从而导致HPV感染的持续存在。